cochlear podcast

Cochlear Launches New Hearing Health Today Podcast

Cochlear Limited the global leader in implantable hearing solutions, today announced a new podcast for hearing health professionals, Hearing Health Today. The podcast is an educational and thought-provoking series that explores the key challenges, trends and opportunities in the delivery of hearing care today, and into the future. The fortnightly podcast will feature hearing health experts…

Read More
cochlear remote check programming

FDA Gives Expedited Approval of Cochlear’s Remote Check Solution for Cochlear Implants

CENTENNIAL, COLORADO — Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, has obtained U.S. Food and Drug Administration (FDA) approval for its Remote Check solution. According to the company’s announcement, this approval is “the first step in commercializing the product offering, which is anticipated by the end of 2020”. Cochlear says that it…

Read More
cochlear equity raise covid19

Cochlear Announces Launch of $850M Equity Raising

Hearing implant maker, Cochlear, has announced today that the company will be undergoing capital raising efforts to ensure the company “remains strong during and after the COVID-19 pandemic.” The company looks to raise over $500M USD ($850M AUS). The company, which had reduced its profit forecast in early February due to the impact of the…

Read More
cochlear implant fda approval 9 months

Cochlear Receives FDA Approval to Lower Age of Cochlear Implantation to 9 months

CENTENNIAL, COLORADO — Cochlear Limited, the global leader in implantable hearing solutions, announced that it has obtained U.S. Food and Drug Administration (FDA) approval to lower the age of cochlear implantation from 12 months to 9 months for children with bilateral, profound sensorineural hearing loss.  This approval “ensures children born deaf have earlier access to a…

Read More
cochlear osia implant system

New Cochlear Osia 2 Hearing Implant System Receives FDA Clearance

CENTENNIAL, COLORADO— Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, has announced the U.S. Food and Drug Administration (FDA) clearance of the new Cochlear™ Osia® 2 System. The Osia System is “the world’s first active osseointegrated steady-state implant (OSI), a new category of bone conduction hearing solutions” that uses digital piezoelectric stimulation…

Read More
resound cochlear smart alliance

Cochlear and GN Hearing Announce New, Expanded Partnership

SYDNEY AUSTRALIA & COPENHAGEN, DENMARK — Hearing implant maker, Cochlear, and GN announced today that the two companies have signed an agreement to significantly expand their Smart Hearing Alliance collaboration. The Smart Hearing Alliance was established in 2015 to develop integrated hearing solutions – giving hearing aid and cochlear implant recipients access to the latest…

Read More
cochlear patent lawsuit

Cochlear Loses US Patent Case, Ordered to Pay $268 Million in Damages; Company Plans to Appeal Ruling

In an announcement Monday, a U.S. district court has ordered Australian hearing implant maker, Cochlear, to pay $268.1 million in damages in a patent infringement case brought against the company filed by the Alfred E. Mann Foundation for Scientific Research and Advanced Bionics LLC.  Following the announcement, the company’s stock was trading down nearly four…

Read More

Cochlear Ltd Pledges $10 million to Johns Hopkins to Fund Hearing Loss and Public Health Research

CENTENNIAL, COLORADO — Cochlear Limited announced that it will be pledging a gift of $10 million to the Johns Hopkins Bloomberg School of Public Health to establish the Cochlear Center for Hearing and Public Health. According to the announcement, the new Center will be led by Dr. Frank Lin and will be the first of…

Read More
cochlear sensorion hearing loss drug sens 401

Cochlear Ltd Announces Research Study Collaboration, and $1.9M Placement, with Sensorion

SYDNEY, AUSTRALIA — Hearing implant maker, Cochlear Ltd, announced a strategic collaboration with French biotech firm, Sensorion. The collaboration will examine therapeutic approaches using Sensorion’s investigative drug, SENS-401, in combination with cochlear implants. According to the press release, the preclinical studies will be initiated in 2018, with possible clinical trials beginining as early as 2019.…

Read More
cochlear implant remote programming telehealth

Remote Programming via Telemedicine Approved for Cochlear Implants

Telemedicine appears to be gaining some traction within audiology circles, as the U.S. Food and Drug Administration approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System on November 17. The remote programming feature is indicated for patients who have had six months of experience with their cochlear implant sound processor…

Read More